Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

International Stem Cell (ISCO) Other Non-Current Assets (2016 - 2025)

International Stem Cell (ISCO) has disclosed Other Non-Current Assets for 16 consecutive years, with $31000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Other Non-Current Assets changed 0.0% to $31000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $31000.0, a 0.0% change, with the full-year FY2024 number at $31000.0, changed 0.0% from a year prior.
  • Other Non-Current Assets was $31000.0 for Q3 2025 at International Stem Cell, roughly flat from $31000.0 in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $50000.0 in Q1 2021 to a low of $31000.0 in Q4 2023.
  • A 5-year average of $35263.2 and a median of $33000.0 in 2022 define the central range for Other Non-Current Assets.
  • Peak YoY movement for Other Non-Current Assets: plummeted 38.1% in 2021, then increased 12.12% in 2023.
  • International Stem Cell's Other Non-Current Assets stood at $39000.0 in 2021, then decreased by 15.38% to $33000.0 in 2022, then decreased by 6.06% to $31000.0 in 2023, then changed by 0.0% to $31000.0 in 2024, then changed by 0.0% to $31000.0 in 2025.
  • Per Business Quant, the three most recent readings for ISCO's Other Non-Current Assets are $31000.0 (Q3 2025), $31000.0 (Q2 2025), and $31000.0 (Q1 2025).